Company Filing History:
Years Active: 2015
Title: Innovations by Jeffrey P Conn
Introduction
Jeffrey P Conn is a notable inventor based in Brentwood, TN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the muscarinic acetylcholine receptor.
Latest Patents
Conn holds a patent for "Substituted 1H-pyrazolo[3',4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4." This invention relates to substituted 1H-pyrazolo[3',4′:4,5]thieno[2,3-b]pyridin-3-amine analogs and derivatives, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M4. The patent also includes synthesis methods for making these compounds, pharmaceutical compositions comprising them, and methods for treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction.
Career Highlights
Conn is affiliated with Vanderbilt University, where he has been involved in groundbreaking research. His work has led to advancements in understanding and treating conditions related to the muscarinic acetylcholine receptor.
Collaborations
Some of his notable coworkers include Craig William Lindsley and Michael R Wood, who have collaborated with him on various research projects.
Conclusion
Jeffrey P Conn's innovative work in pharmacology and his patent contributions highlight his role as a significant figure in the field. His research continues to pave the way for new treatments for neurological and psychiatric disorders.